Anavex Life Sciences Corp (AVXL)

[LakeshoreLeo1953]

All well and good Xena, but those who argue the patent issue WELL

Can and do cite the "extension" tactics "generally" are all that are available to A2-73 given the original Greek protections.

A3-71 is a different story and perhaps the Gold Ring that will actually
make AVXL a Player.

My middle of the road remains.....

I like the new direction of scientific investigation.
I doubt the arguments to date by AVXL will sway the USPTO examiner.
I think 7 years (or so) from today's date is what an investor gets
out of A 2-73 exclusivity.

I could be off on any or all, but not by a significant factor and
That position is not uninformed.